Mediclinic reports R740m loss for year
Mediclinic International posts R740m loss, knocked by series of one-off items, including refinancing of Swiss debt and buyout of interests in its Dubai operationNew pharmaceutical body to tackle drug registration delay
First order of business for Innovative Pharmaceutical Association of SA will be dealing with delays in registering new products
Netcare CEO says Competition Commission must also probe pharmaceuticals
CEO Richard Friedland says he is disappointed that Competition Commission’s planned inquiry into private healthcare sector will exclude pharmaceutical sector
Takeover expected to make Cipla Medpro’s pricing more competitive
Move by India’s Cipla offers savings, and may put pressure on competitors in South Africa
Netcare’s earnings rise, helped in part by weaker rand
Hospital group says half-year earnings driven by strong performance at local operations, while UK profit dented by higher proportion of National Health Service patients
Motsoaledi urges medical schemes to pay for cancer vaccines
Minister says the government will begin providing cervical cancer vaccines to girls from poor families attending state schools from February, and calls on funders to help
Private health costs inquiry welcomed
Life Healthcare calls for ‘holistic’ Competition Commission probe
Life Healthcare’s profit growth slows
Private hospital group remains optimistic about Indian expansion, SA prospects despite tough conditions, as earnings growth slows in half-year to March
Adcock stock on track to gain from bidding war
JPMorgan Chase says Adcock could gain a further 12% on top of Thursday’s 30-month high after it received takeover offers
French drug firm touted as Adcock bidder
Speculation is running high that French pharmaceutical giant Sanofi is firmly in the running
Bidvest still wants Adcock, says Joffe
Bidvest CE Brian Joffe says bid for Adcock Ingram stands though he wants details of contracts with Swiss drugs supplier
Discovery medical scheme members to get answers from administrator in June
Members of Discovery Health Medical Scheme to get answers at AGM over whether they are getting value for money from administrator Discovery HealthRuling could help Adcock get drugs back on market
Australian medicines regulator decision could pave way for Adcock Ingram to get its once highly lucrative DPP-containing painkillers back on SA market
Competition Commission to probe healthcare costs, says Patel
Competition Commission to conduct first-ever market inquiry under Competition Amendment Act, says Economic Development Minister Ebrahim Patel
- Bidding war looms after surprise Adcock offer
- Selfmed duo face inquiry over ‘failed governance’
- Nehawu vows to maintain Netcare strike until demands met
- Private hospitals drive medical imaging investment
- Shareholders want sight of Cipla Medpro supply deal
- Litha stock tanks despite profit turnaround
- Bidvest may have rival bidder for Adcock Ingram
- Bidvest may see Adcock as defensive play
- Cipla Medpro South Africa sees earnings fall 32%
- Bidvest sees Adcock Ingram’s similarities
- Aspen makes offer for Pfizer baby formula units
- Johnson & Johnson may cause wrinkles in the Botox market
- Restatement to hit Cipla Medpro earnings
- Bidvest offer for Adcock a ‘cheeky move’
- Bidvest defends offer but Adcock says it has lapsed
- Medical device industry says revised BEE codes ‘unfair’
- Competition watchdog to get ‘invasive’ new powers
- Discovery Health chief executive Adrian Gore on profits vs people
- Not so sweet surprise in Cipla's India deal
- Virgin Active not resting on its laurels in South Africa
- Cipla India ups offer for South African firm
- Litha’s earnings plunge as rand weakens
- Government’s ARV programme ‘increasing life expectancy’
- Pharmaceutical firms eye Africa
- Hospices in South Africa cut capacity as US reduces funding
- Cipla Medpro denies acquisition talks put on hold
- Aspen targets Netherlands plant
- Discovery backs global Charter for Healthy Living
- Medical aid chairman loses bid to halt probe
- Grant spat puts future of McCord in doubt
- Take a digipill and call me tomorrow
- Cadres make way for new hospital CEOs
- Payments to former Cipla Medpro CEO ‘unlawful’
- Cipla calls former CEO’s allegations ‘provocative and misleading’
- Ousted CEO sues Cipla in multimillion-rand payout wrangle
- Aspen profit up on sales, costs savings
- State to introduce three-in-one AIDS pill
- Patent board rules against Bayer in blow for 'big pharma'
- Mining company is committed to keeping its employees healthy
- Minister looks into establishing regulated pricing
- Response to epidemic gathers momentum: report
- SUMMIT TV: South Africa leads when it comes to Aids
- Lack of tariff guide adds to spiralling costs
- Discovery and IBM SA members to vote on merger
| All Share | 41836.02 | 0.05% | up |
| Top 40 | 37309.67 | 0.02% | up |
| Financial 15 | 11971.78 | -0.24% | down |
| Industrial 25 | 47413.26 | -0.51% | down |
| Resource 10 | 47611.41 | 1.30% | up |
Data supplied by I-Net Bridge
| FTSE 100 | 6840.27 | 0.54% | up |
| Dow Jones | 15354.86 | -0.21% | down |
| All Share | 41836.02 | 0.05% | up |
| ASX | 5142.10 | 0.00% | same |
| S&P 500 | 1664.620 | -0.27% | down |
Data supplied by I-Net Bridge
| USD/ZAR | 9.5847 | 0.40% | up |
| GBP/ZAR | 14.4071 | -0.42% | down |
| EUR/ZAR | 12.3104 | -0.15% | down |
| JPY/ZAR | 0.0929 | -0.24% | down |
| AUD/ZAR | 9.2773 | -0.93% | down |
Data supplied by I-Net Bridge
| Gold | 1356.7570 | -1.25% | down |
| Platinum | 1460.5000 | 0.24% | up |
| Silver | 22.3183 | -0.59% | down |
| Palladium | 746.5000 | 0.88% | up |
| Brent Crude Oil | 102.490 | -1.37% | down |
Data supplied by I-Net Bridge
Share search
Top 100 Companies 2012
Click here to view or download Business Times's full Top 100 Companies 2012 report (PDF, 7MB)
Register/Login
Close XMy News
You can only set up or view personalised news headlines when you are logged in as a registered user. Thereafter you can choose the sectors of industry in which you are interested, and the latest articles from those sectors will display in this area of your console.
Login or Register.Top Stories
My Watchlist
You can only set up or view your share watchlist when you are logged in as a registered user. Thereafter you can select a list of companies and enter your share details to monitor their performance.
Login or Register.My Clippings
You can only clip articles when you are logged in as a registered user. Thereafter you can click on the "Read later" icon at the top of an article to save it to this area of your console, where you can return to read it at any time.
Login or Register.Change: 0.05%
Change: 0.02%
Change: -0.24%
Change: -0.51%
Change: 1.30%
Data supplied by I-Net Bridge
Change: 0.54%
Change: -0.28%
Change: 0.00%
Change: 0.00%
Change: -0.04%
Data supplied by I-Net Bridge
Change: 0.29%
Change: -0.52%
Change: -0.23%
Change: -0.35%
Change: -1.05%
Data supplied by I-Net Bridge
Change: -1.12%
Change: 0.38%
Change: -0.22%
Change: 0.88%
Change: -1.47%
Data supplied by I-Net Bridge